Opus Genetics (IRD) EBITDA Margin (2010 - 2026)
Opus Genetics (IRD) reported EBITDA Margin of 3038.25% for Q1 2026, down 285074.0% year-over-year from N/an in Q1 2025, and down 610.7% on a QoQ basis from 427.5% in Q4 2025.
Opus Genetics (IRD) has 8 years of EBITDA Margin data on file, last reported at 3038.25% in Q1 2026.
- Quarterly EBITDA Margin fell 285074.0% year-over-year to 3038.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 892.36% (down 46295.0% YoY) and the FY2025 annual result came in at 349.33%, up 17407.0% from the prior year.
- EBITDA Margin eased to 3038.25% in Q1 2026 per IRD's latest filing, from 427.5% in the prior quarter.
- Across five years, EBITDA Margin topped out at 85.17% in Q4 2022 and bottomed at 3038.25% in Q1 2026.
- The 5-year median for EBITDA Margin is 307.33% (2023), against an average of 515.75%.
- The widest annual swing landed in 2025, when EBITDA Margin surged 44083 bps; it then sank 285074 bps in 2026.
- Tracing IRD's EBITDA Margin over 5 years: stood at 85.17% in 2022, then slumped by 433 bps to 283.56% in 2023, then slumped by 188 bps to 816.71% in 2024, then jumped by 48 bps to 427.5% in 2025, then tumbled by 611 bps to 3038.25% in 2026.
- Per Business Quant, the three latest IRD EBITDA Margin figures stand at 3038.25% (Q1 2026), 427.5% (Q4 2025), and 566.87% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -3,038.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,038.25% |
| Dec 31, 2025 | -427.50% |
| Sep 30, 2025 | -566.87% |
| Jun 30, 2025 | -257.46% |
| Mar 31, 2025 | -187.51% |
| Dec 31, 2024 | -816.71% |
| Sep 30, 2024 | -194.62% |
| Jun 30, 2024 | -698.29% |
| Mar 31, 2024 | -415.31% |
| Dec 31, 2023 | -283.56% |
| Sep 30, 2023 | 46.59% |
| Jun 30, 2023 | -135.03% |
| Mar 31, 2023 | -331.10% |
| Dec 31, 2022 | 85.17% |
| Sep 30, 2021 | -865.03% |
| Jun 30, 2021 | -7,136.00% |
| Mar 31, 2020 | -268.52% |
| Jun 30, 2010 | -17,008.07% |